|
Market Cap (24-Jun) TBC |
Close (30-Jun) $0.001 |
Volume (30-Jun) 4,631,202 |
Shortsold (23-Jul) 66,820 (0.00%) (487th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS - |
MEB released this announcement to the ASX on 21 July 2022, 9:18. The announcement is marked as price sensitive, and is 1 page(s) in length and 133.4kb in size.
You can view all announcements from MEB and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from MEB | |
|---|---|
| Change of Director's Interest Notice - David Trimboli | 22 June 2023, 9:38 |
| Change of Director's Interest Notice - Chris Ntoumenopoulos | 22 June 2023, 9:37 |
| Notification regarding unquoted securities - MEB | 22 June 2023, 9:34 |
| Sleep Analysis Depressive Burden Study Clinical Trial | 21 July 2022, 9:18 |
| Update - Proposed issue of securities - MEB | 14 July 2022, 9:18 |
| Notice of Extraordinary General Meeting/Proxy Form | 14 July 2022, 9:13 |
| Notification of cessation of securities - MEB | 12 July 2022, 16:14 |
You must be logged in to post a reply.
Medibio 